{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T12:19:57Z","timestamp":1773231597650,"version":"3.50.1"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,6,23]],"date-time":"2023-06-23T00:00:00Z","timestamp":1687478400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,6,23]],"date-time":"2023-06-23T00:00:00Z","timestamp":1687478400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eye"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1038\/s41433-023-02635-4","type":"journal-article","created":{"date-parts":[[2023,6,23]],"date-time":"2023-06-23T11:02:54Z","timestamp":1687518174000},"page":"82-88","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Feasibility of oral doxycycline as first-line therapy for conjunctival mucosa-associated lymphoid tissue lymphoma"],"prefix":"10.1038","volume":"38","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9916-0332","authenticated-orcid":false,"given":"Se Hyun","family":"Choi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Min Kyu","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tae Min","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7314-2267","authenticated-orcid":false,"given":"Hyuk Jin","family":"Choi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,6,23]]},"reference":[{"key":"2635_CR1","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.ophtha.2017.05.037","volume":"125","author":"MT Yen","year":"2018","unstructured":"Yen MT, Bilyk JR, Wladis EJ, Bradley EA, Mawn LA. Treatments for ocular adnexal lymphoma: a report by the american academy of ophthalmology. Ophthalmology. 2018;125:127\u201336.","journal-title":"Ophthalmology"},{"key":"2635_CR2","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1182\/blood-2008-12-195453","volume":"114","author":"A Stefanovic","year":"2009","unstructured":"Stefanovic A, Lossos IS. Extranodal marginal zone lymphoma of the ocular adnexa. Blood. 2009;114:501\u201310.","journal-title":"Blood"},{"key":"2635_CR3","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1097\/PAP.0b013e3181e4abdb","volume":"17","author":"PA McKelvie","year":"2010","unstructured":"McKelvie PA. Ocular adnexal lymphomas: a review. Adv Anat Pathol. 2010;17:251\u201361.","journal-title":"Adv Anat Pathol"},{"key":"2635_CR4","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1016\/j.survophthal.2015.05.001","volume":"60","author":"MM Kirkegaard","year":"2015","unstructured":"Kirkegaard MM, Coupland SE, Prause JU, Heegaard S. Malignant lymphoma of the conjunctiva. Surv Ophthalmol. 2015;60:444\u201358.","journal-title":"Surv Ophthalmol"},{"key":"2635_CR5","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s40662-019-0146-1","volume":"6","author":"RE Tanenbaum","year":"2019","unstructured":"Tanenbaum RE, Galor A, Dubovy SR, Karp CL. Classification, diagnosis, and management of conjunctival lymphoma. Eye Vis (Lond). 2019;6:22.","journal-title":"Eye Vis (Lond)"},{"key":"2635_CR6","doi-asserted-by":"publisher","first-page":"1994","DOI":"10.1016\/S0161-6420(95)30764-6","volume":"102","author":"WL White","year":"1995","unstructured":"White WL, Ferry JA, Harris NL, Grove AS Jr. Ocular adnexal lymphoma. A clinicopathologic study with identification of lymphomas of mucosa-associated lymphoid tissue type. Ophthalmology. 1995;102:1994\u20132006.","journal-title":"Ophthalmology"},{"key":"2635_CR7","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.medcli.2018.09.006","volume":"152","author":"A Salar","year":"2019","unstructured":"Salar A. Gastric MALT lymphoma and Helicobacter pylori. Med Clin (Barc). 2019;152:65\u201371.","journal-title":"Med Clin (Barc)"},{"key":"2635_CR8","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1080\/1040841X.2020.1760786","volume":"46","author":"C Melenotte","year":"2020","unstructured":"Melenotte C, Mezouar S, Mege JL, Gorvel JP, Kroemer G, Raoult D. Bacterial infection and non-Hodgkin\u2019s lymphoma. Crit Rev Microbiol. 2020;46:270\u201387.","journal-title":"Crit Rev Microbiol"},{"key":"2635_CR9","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1093\/jnci\/djj373","volume":"98","author":"AJ Ferreri","year":"2006","unstructured":"Ferreri AJ, Ponzoni M, Guidoboni M, Resti AG, Politi LS, Cortelazzo S, et al. Bacteria-eradicating therapy with doxycycline in ocular adnexal MALT lymphoma: a multicenter prospective trial. J Natl Cancer Inst. 2006;98:1375\u201382.","journal-title":"J Natl Cancer Inst"},{"key":"2635_CR10","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1111\/j.1349-7006.2010.01502.x","volume":"101","author":"TM Kim","year":"2010","unstructured":"Kim TM, Kim KH, Lee MJ, Jeon YK, Lee SH, Kim DW, et al. First-line therapy with doxycycline in ocular adnexal mucosa-associated lymphoid tissue lymphoma: a retrospective analysis of clinical predictors. Cancer Sci. 2010;101:1199\u2013203.","journal-title":"Cancer Sci"},{"key":"2635_CR11","doi-asserted-by":"publisher","first-page":"2988","DOI":"10.1200\/JCO.2011.41.4466","volume":"30","author":"AJ Ferreri","year":"2012","unstructured":"Ferreri AJ, Govi S, Pasini E, Mappa S, Bertoni F, Zaja F, et al. Chlamydophila psittaci eradication with doxycycline as first-line targeted therapy for ocular adnexae lymphoma: final results of an international phase II trial. J Clin Oncol. 2012;30:2988\u201394.","journal-title":"J Clin Oncol"},{"key":"2635_CR12","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1007\/s00277-014-2240-8","volume":"94","author":"JJ Han","year":"2015","unstructured":"Han JJ, Kim TM, Jeon YK, Kim MK, Khwarg SI, Kim CW, et al. Long-term outcomes of first-line treatment with doxycycline in patients with previously untreated ocular adnexal marginal zone B cell lymphoma. Ann Hematol. 2015;94:575\u201381.","journal-title":"Ann Hematol"},{"key":"2635_CR13","doi-asserted-by":"publisher","DOI":"10.1186\/1750-9378-7-8","volume":"7","author":"F Collina","year":"2012","unstructured":"Collina F, De Chiara A, De Renzo A, De Rosa G, Botti G, Franco R. Chlamydia psittaci in ocular adnexa MALT lymphoma: a possible role in lymphomagenesis and a different geographical distribution. Infect Agent Cancer. 2012;7:8.","journal-title":"Infect Agent Cancer"},{"key":"2635_CR14","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1093\/jnci\/djh102","volume":"96","author":"AJ Ferreri","year":"2004","unstructured":"Ferreri AJ, Guidoboni M, Ponzoni M, De Conciliis C, Dell\u2019Oro S, Fleischhauer K, et al. Evidence for an association between Chlamydia psittaci and ocular adnexal lymphomas. J Natl Cancer Inst. 2004;96:586\u201394.","journal-title":"J Natl Cancer Inst"},{"key":"2635_CR15","doi-asserted-by":"publisher","first-page":"5794","DOI":"10.1158\/1078-0432.CCR-08-0676","volume":"14","author":"M Ponzoni","year":"2008","unstructured":"Ponzoni M, Ferreri AJ, Guidoboni M, Lettini AA, Cangi MG, Pasini E, et al. Chlamydia infection and lymphomas: association beyond ocular adnexal lymphomas highlighted by multiple detection methods. Clin Cancer Res. 2008;14:5794\u20135800.","journal-title":"Clin Cancer Res"},{"key":"2635_CR16","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1002\/ajh.20962","volume":"82","author":"C Yoo","year":"2007","unstructured":"Yoo C, Ryu MH, Huh J, Park JH, Kang HJ, Ahn HS, et al. Chlamydia psittaci infection and clinicopathologic analysis of ocular adnexal lymphomas in Korea. Am J Hematol. 2007;82:821\u20133.","journal-title":"Am J Hematol"},{"key":"2635_CR17","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1111\/j.1365-2141.2005.05943.x","volume":"132","author":"M Daibata","year":"2006","unstructured":"Daibata M, Nemoto Y, Togitani K, Fukushima A, Ueno H, Ouchi K, et al. Absence of Chlamydia psittaci in ocular adnexal lymphoma from Japanese patients. Br J Haematol. 2006;132:651\u20132.","journal-title":"Br J Haematol"},{"key":"2635_CR18","doi-asserted-by":"publisher","first-page":"1292","DOI":"10.1016\/j.leukres.2007.10.013","volume":"32","author":"A Aigelsreiter","year":"2008","unstructured":"Aigelsreiter A, Leitner E, Deutsch AJ, Kessler HH, Stelzl E, Beham-Schmid C, et al. Chlamydia psittaci in MALT lymphomas of ocular adnexals: the Austrian experience. Leuk Res. 2008;32:1292\u20134.","journal-title":"Leuk Res"},{"key":"2635_CR19","doi-asserted-by":"publisher","first-page":"2031","DOI":"10.3109\/10428194.2010.513751","volume":"51","author":"D Zhang","year":"2010","unstructured":"Zhang D, Dong L, Li H, Jin H, Ye H, Zhou X, et al. Ocular adnexal mucosa-associated lymphoid tissue lymphoma in Northern China: high frequency of numerical chromosomal changes and no evidence of an association with Chlamydia psittaci. Leuk Lymphoma. 2010;51:2031\u20138.","journal-title":"Leuk Lymphoma"},{"key":"2635_CR20","doi-asserted-by":"publisher","first-page":"4384","DOI":"10.1182\/blood-2008-07-077982","volume":"112","author":"ES Jaffe","year":"2008","unstructured":"Jaffe ES, Harris NL, Stein H, Isaacson PG. Classification of lymphoid neoplasms: the microscope as a tool for disease discovery. Blood. 2008;112:4384\u201399.","journal-title":"Blood"},{"key":"2635_CR21","doi-asserted-by":"publisher","first-page":"2375","DOI":"10.1182\/blood-2016-01-643569","volume":"127","author":"SH Swerdlow","year":"2016","unstructured":"Swerdlow SH, Campo E, Pileri SA, Harris NL, Stein H, Siebert R, et al. The 2016 revision of the World Health Organization classification of lymphoid neoplasms. Blood. 2016;127:2375\u201390.","journal-title":"Blood"},{"key":"2635_CR22","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.5858\/133.8.1262","volume":"133","author":"SE Coupland","year":"2009","unstructured":"Coupland SE, White VA, Rootman J, Damato B, Finger PT. A TNM-based clinical staging system of ocular adnexal lymphomas. Arch Pathol Lab Med. 2009;133:1262\u20137.","journal-title":"Arch Pathol Lab Med"},{"key":"2635_CR23","doi-asserted-by":"publisher","first-page":"1244","DOI":"10.1200\/JCO.1999.17.4.1244","volume":"17","author":"BD Cheson","year":"1999","unstructured":"Cheson BD, Horning SJ, Coiffier B, Shipp MA, Fisher RI, Connors JM, et al. Report of an international workshop to standardize response criteria for non-Hodgkin\u2019s lymphomas. NCI Sponsored International Working Group. J Clin Oncol. 1999;17:1244.","journal-title":"J Clin Oncol"},{"key":"2635_CR24","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1136\/bjophthalmol-2020-315875","volume":"105","author":"M Kwon","year":"2021","unstructured":"Kwon M, Lee JS, Lee C, Yoon DH, Sa HS. Prognostic factors for relapse and survival among patients with ocular adnexal lymphoma: validation of the eighth edition of the American Joint Committee on Cancer (AJCC) TNM classification. Br J Ophthalmol. 2021;105:279\u201384.","journal-title":"Br J Ophthalmol"},{"key":"2635_CR25","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1002\/ajh.10332","volume":"73","author":"EY Cho","year":"2003","unstructured":"Cho EY, Han JJ, Ree HJ, Ko YH, Kang YK, Ahn HS, et al. Clinicopathologic analysis of ocular adnexal lymphomas: extranodal marginal zone b-cell lymphoma constitutes the vast majority of ocular lymphomas among Koreans and affects younger patients. Am J Hematol. 2003;73:87\u201396.","journal-title":"Am J Hematol"},{"key":"2635_CR26","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3341\/kjo.2006.20.1.7","volume":"20","author":"JM Woo","year":"2006","unstructured":"Woo JM, Tang CK, Rho MS, Lee JH, Kwon HC, Ahn HB. The clinical characteristics and treatment results of ocular adnexal lymphoma. Korean J Ophthalmol. 2006;20:7\u201312.","journal-title":"Korean J Ophthalmol"},{"key":"2635_CR27","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1097\/IOP.0b013e318030b058","volume":"23","author":"JS Yoon","year":"2007","unstructured":"Yoon JS, Ma KT, Kim SJ, Kook K, Lee SY. Prognosis for patients in a Korean population with ocular adnexal lymphoproliferative lesions. Ophthalmic Plast Reconstr Surg. 2007;23:94\u201399.","journal-title":"Ophthalmic Plast Reconstr Surg"},{"key":"2635_CR28","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1136\/bjophthalmol-2017-310741","volume":"102","author":"SW Nam","year":"2018","unstructured":"Nam SW, Woo KI, Kim YD. Characteristics of primary extranodal marginal zone B-cell lymphoma in Korea: conjunctiva versus other ocular adnexa. Br J Ophthalmol. 2018;102:502\u20138.","journal-title":"Br J Ophthalmol"}],"updated-by":[{"DOI":"10.1038\/s41433-023-02690-x","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2023,8,18]],"date-time":"2023-08-18T00:00:00Z","timestamp":1692316800000}}],"container-title":["Eye"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41433-023-02635-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41433-023-02635-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41433-023-02635-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,4]],"date-time":"2024-01-04T00:04:11Z","timestamp":1704326651000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41433-023-02635-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,23]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,1]]}},"alternative-id":["2635"],"URL":"https:\/\/doi.org\/10.1038\/s41433-023-02635-4","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-2244889\/v1","asserted-by":"object"}]},"ISSN":["0950-222X","1476-5454"],"issn-type":[{"value":"0950-222X","type":"print"},{"value":"1476-5454","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,23]]},"assertion":[{"value":"6 November 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 May 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 June 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 June 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 August 2023","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1038\/s41433-023-02690-x","URL":"https:\/\/doi.org\/10.1038\/s41433-023-02690-x","order":8,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}